The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

NCT01861522 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

473

Enrollment

INDUSTRY

Sponsor class

Conditions

Perennial Allergic Rhinitis

Interventions

DRUG: Bepotastine besilate
DRUG: Placebo

Sponsor

Tanabe Pharma Corporation